Abstract
The BRCA1 tumor-suppressor protein has been implicated in the regulation of transcription, DNA repair, proliferation, and apoptosis. BRCA1 is expressed in many proliferative tissues and this is at least in part due to E2F-dependent transcriptional control. In this study, inactivation of a conditional murine Brca1 allele was achieved in a variety of epithelial tissues via expression of the Cre recombinase under the control of a keratin 5 (K5) promoter. The K5 Cre:Brca1 conditional knockout mice exhibited modest epidermal hyperproliferation, increased apoptosis, and were predisposed to developing tumors in the skin, the inner ear canal, and the oral epithelium after 1 year of age. Overexpression of the E2F1 transcription factor in K5 Cre:Brca1 conditional knockout mice dramatically accelerated tumor development. In addition, Brca1 heterozygous female mice that had elevated E2F1 expression developed tumors of the reproductive tract at high incidence. These findings demonstrate that in mice Brca1 functions as a tumor suppressor in other epithelial tissues in addition to the mammary gland. Moreover, inactivation of Brca1 is shown to cooperate with deregulation of the Rb-E2F1 pathway to promote tumorigenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho MJ, Jensen RA and Liu ET . (1999). Proc. Natl. Acad. Sci. USA, 96, 11866–11871.
Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S and Karlan BY . (2000). Cancer Res., 60, 5329–5333.
Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE and Dobrovic A . (2000). Carcinogenesis, 21, 147–151.
Brakebusch C, Grose R, Quondamatteo F, Ramirez A, Jorcano JL, Pirro A, Svensson M, Herken R, Sasaki T, Timpl R, Werner S and Fassler R . (2000). EMBO J., 19, 3990–4003.
Chapman MS and Verma IM . (1996). Nature, 382, 678–679.
Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL and Lee WH . (1996). Cancer Res., 56, 3168–3172.
Cortez D, Wang Y, Qin J and Elledge SJ . (1999). Science, 286, 1162–1166.
Couch FJ and Weber BL . (1996). Hum. Mutat., 8, 8–18.
Crook T, Brooks LA, Crossland S, Osin P, Barker KT, Waller J, Philp E, Smith PD, Yulug I, Peto J, Parker G, Allday MJ, Crompton MR and Gusterson BA . (1998). Oncogene, 17, 1681–1689.
Crook T, Crossland S, Crompton MR, Osin P and Gusterson BA . (1997). Lancet, 350, 638–639.
Eisinger F, Jacquemier J, Guinebretiere JM, Birnbaum D and Sobol H . (1997). Lancet, 350, 1101.
Esteller M, Corn PG, Baylin SB and Herman JG . (2001). Cancer Res., 61, 3225–3229.
Fan S, Wang JA, Yaun R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID and Rosen EM . (1999). Science, 284, 1354–1356.
Futreal PA, Liu Q, Shattuck-Evans D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swenson J, Miki T, Eddington K, McClure M, Frye C, Weaver-Feldhaus J and Ding W . (1994). Science, 266, 120–122.
Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B and Khanna KK . (2000). Cancer Res., 60, 3299–3304.
Gatei M, Zhou BB, Hobson K, Scott S, Young D and Khanna KK . (2001). J. Biol. Chem., 276, 17276–17280.
Gowen LC, Avrustskaya AV, Latour AM, Koller BH and Leadon SA . (1998). Science, 281, 1009–1012.
Gowen LC, Johnson BL, Latour AM, Sulik KK and Koller BH . (1996). Nat. Genet., 12, 191–194.
Gudas JM, Li T, Nguyen H, Jensen D, Rauscher III FJ and Cowan KH . (1996). Cell Growth Differ., 7, 717–723.
Hakem R, de la Pompa J, Sirard C, Mo R, Woo M, Hakem A, Wakeman A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J and Mak TW . (1996). Cell, 85, 1009–1023.
Harkin PD, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD and Haber DA . (1999). Cell, 97, 575–586.
Hill AD, Doyle JM, McDermott EW and O'Higgins NJ . (1997). Br. J. Surg., 84, 1334–1339.
Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC and Jensen RA . (1996). Nat. Genet., 12, 298–302.
Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albert DM and Windle JJ . (1994). Genes Dev., 8, 1300–1310.
Huber LJ, Yang TW, Sarkisian CJ, Master SR, Deng CX and Chodosh LA . (2001). Mol. Cell. Biol., 21, 4005–4015.
Johannsson O, Loman N, Moller T, Kristoffersson U, Borg A and Olsson H . (1999). Eur. J. Cancer, 35, 1248–1257.
Lane TF, Deng C, Elson A, Lyu MS, Kozak CA and Leder P . (1995). Genes Dev., 9, 2712–2722.
Lee JS, Collins KM, Brown AL, Lee CH and Chung JH . (2000). Nature, 404, 201–204.
Liu CY, Flesken-Nikitin A, Li S, Zeng Y and Lee WH . (1996). Genes Dev., 10, 1835–1843.
Ludwig T, Chapman DL, Papaioannou VE and Efstratiadis A . (1997). Genes Dev., 11, 1226–1241.
Ludwig T, Fisher P, Ganesan S and Efstratiadis A . (2001). Genes Dev., 15, 1188–1193.
Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, Weber BL and Chodosh LA . (1995). Nat. Genet., 11, 17–26.
Miki Y, Swenson J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavitigian S, Liu Q, Cochran C, Bennett LM and Ding W . (1994). Science, 266, 66–71.
Monteiro AN, August A and Hanafusa H . (1996). Proc. Natl. Acad. Sci. USA, 93, 13595–13599.
Ouchi T, Monterio A, August A, Aaronson SA and Hanafusa H . (1998). Proc. Natl. Acad. Sci. USA, 95, 2302–2306.
Pao GM, Janknecht R, Ruffner H, Hunter T and Verma IM . (2000). Proc. Natl. Acad. Sci. USA, 97, 1020–1025.
Pierce AM, Fisher SM, Conti CJ and Johnson DG . (1998a). Oncogene, 16, 1267–1276.
Pierce AM, Gimenez-Conti IB, Schneider-Broussard R, Martinez LA, Conti CJ and Johnson DG . (1998b). Proc. Natl. Acad. Sci. USA, 95, 8858–8863.
Pierce AM, Schneider-Broussard R, Gimenez-Conti IB, Russell JL, Conti CJ and Johnson DG . (1999). Mol. Cell. Biol., 19, 6408–6414.
Polager S, Kalma Y, Berkovich E and Ginsberg D . (2002). Oncogene, 21, 437–446.
Ramirez A, Bravo A, Jorcano JL and Vidal M . (1994). Differentiation, 58, 53–64.
Randrianarison V, Marot D, Foray N, Cabannes J, Meret V, Connault E, Vitrat N, Opolon P, Perricaudet M and Feunteun J . (2001). Cancer Gene Ther., 8, 759–770.
Rao VN, Shao N, Ahmad M and Reddy ES . (1996). Oncogene, 12, 523–528.
Rhei E, Bogomolniy F, Federici MG, Maresco DL, Offit K, Robson ME, Saigo PE and Boyd J . (1998). Cancer Res., 58, 3193–3196.
Rice JC, Ozcelik H, Maxeiner P, Andrulis I and Futscher BW . (2000). Carcinogenesis, 21, 1761–1765.
Ruffner H, Jiang W, Craig AG, Hunter T and Verma IM . (1999). Mol. Cell. Biol., 19, 4843–4854.
Ruffner H and Verma IM . (1997). Proc. Natl. Acad. Sci. USA, 94, 7138–7143.
Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM and Parvin JD . (1997a). Proc. Natl. Acad. Sci. USA, 94, 5605–5610.
Scully R, Chen J, Oches RL, Keegan K, Hoekstra M, Feunteun J and Livingston DM . (1997b). Cell, 90, 425–435.
Scully R, Chen J, Plug A, Xiao Y, Waever D, Feunteun J, Ashley T and Livingston DM . (1997c). Cell, 88, 265–275.
Shen SX, Weaver Z, Xu X, Li C, Weinstein W, Guan XY, Reid T and Deng CX . (1998). Oncogene, 17, 3115–3124.
Sherr CJ . (1996). Science, 274, 1672–1677.
Smedts F, Ramaekers F, Troyanovsky S, Pruszczynski M, Robben H, Lane B, Leigh I, Plantema F and Vooijs P . (1992). Am. J. Pathol., 140, 601–612.
Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Wu GS, Licht JD, Weber BL and El-Deiry WS . (1997). Nature, 389, 187–190.
Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T and Van Dyke T . (1994). Cell, 78, 703–711.
Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB and Weber BL . (1997). Mol. Cell. Biol., 17, 444–452.
Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT . (1995). Nat. Genet., 9, 444–450.
Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ and Abraham RT . (2000). Genes Dev., 14, 2989–3002.
Tong D, Kucera E, Schuster E, Schmutzler RK, Swoboda H, Reinthaller A, Leodolter S and Zeillinger R . (2000). Int. J. Cancer, 88, 319–322.
Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Iglehart JD, Futreal AP and Marks JR . (1996). Cell Growth Differ., 7, 711–715.
Wang A, Pierce AM, Judson-Kremer K, Schneider-Broussard R, MacLeod MC and Johnson DG . (1999). Nucleic Acids Res., 27, 4609–4618.
Wang A, Schneider-Broussard R, Kumar AP, MacLeod MC and Johnson DG . (2000). J. Biol. Chem., 275, 4532–4536.
Wang Q, Zhang H, Kajino K and Greene M . (1998). Oncogene, 17, 1939–1948.
Weaver Z, Montagna C, Xu X, Howard T, Gadina M, Brodie SG, Deng CX and Ried T . (2002). Oncogene, 21, 5097–5107.
Williams BO, Remington L, Albert DM, Mukai S, Bronson RT and Jacks T . (1994). Nat. Genet., 7, 480–484.
Wilson CA, Payton MN, Elliott GS, Buaas FW, Cajulis EE, Grosshans D, Ramos L, Reese DM, Slamon DJ and Calzone FJ . (1997). Oncogene, 14, 1–16.
Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM and Baer R . (1996). Nat. Genet., 14, 430–440.
Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC and Deng CX . (2001). Nat. Genet., 28, 266–271.
Xu X, Wagner KU, Larson D, Weaver Z, Li C, Reid T, Hennighausen L, Wynshaw-Boris A and Deng CX . (1999a). Nat. Genet., 22, 37–43.
Xu X, Weaver KU, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Reid T and Deng CX . (1999b). Mol. Cell, 3, 389–395.
Yarden RI and Brody LC . (1999). Proc. Natl. Acad. Sci. USA, 96, 4983–4988.
Yu X, Wu LC, Bowcock AM, Aronheim A and Baer R . (1998). J. Biol. Chem., 273, 25388–25392.
Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, Weber BL and El-Deiry WS . (1998). Oncogene, 16, 1713–1721.
Zhong Q, Chen CF, Li S, Wang CC, Xiao J, Chen PL, Sharp ZD and Lee WH . (1999). Science, 285, 747–750.
Acknowledgements
We thank Dr Dennis Johnston for his expert statistical analysis, Pam Blau and Stephanie Clifford for their technical assistance, Dr Lezlee Coghlan, Dale Weiss, and co-workers for animal care, Dr Irma Gimenez-Conti, Nancy Abbey, and co-workers for the immunohistochemistry, Chris Yone and Joi Holcomb for artwork. We also thank Dr Xiaoling Xu for the Brca1 probe for Southern analysis. This work was supported by grants from the National Institute of Health (U01 ES11047 and a T-32 National Service Award Training Grant CA 09480 to TRB).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Berton, T., Matsumoto, T., Page, A. et al. Tumor formation in mice with conditional inactivation of Brca1 in epithelial tissues. Oncogene 22, 5415–5426 (2003). https://doi.org/10.1038/sj.onc.1206825
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206825
Keywords
This article is cited by
-
Lamin B1 is required for mature neuron-specific gene expression during olfactory sensory neuron differentiation
Nature Communications (2017)
-
CtBP1 Overexpression in Keratinocytes Perturbs Skin Homeostasis
Journal of Investigative Dermatology (2014)
-
Mouse models of BRCA1 and their application to breast cancer research
Cancer and Metastasis Reviews (2013)
-
Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1
Oncogene (2010)
-
TGFβ signaling in head and neck squamous cell carcinoma
Oncogene (2010)